Latest Breaking News On - David nikodem - Page 1 : comparemela.com

Metadeq Diagnostics Announces Three HeparDx™ Posters will be Presented at EASL SLD Summit 2023

HeparDx is an emerging NASH/MASH and liver fibrosis blood test designed to diagnose patients earlier and monitor disease progression The data presentations add.

Czech republicCity ofUnited kingdomUnited statesStephen harrisonJuliane snowdenDaniel whittakerDavid nikodemPrnewswire metadeq diagnostics incMetadeq incAmerican diabetes associationOratorium groupMetadeq advisory board chairmanMetadeq chief executive officerPrivate securities litigation reform actClin diabetes

Inventiva announces a financing of approximately €35 7 million from new and existing investors, consisting of a €30 6 million reserved capital increase and a €5 1 million issuance of royalty certificates

Daix , Long Island City , August 31, 2023 – Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with.

France generalUnited kingdomNew yorkUnited statesAude lepreuxPascaline clercPierre broquaDavid nikodemEuropean investment bankEuropean parliamentEnterprise associatesPatricial bankEuropean unionFinancial servicesGlobal external affairsQatar holding

INVENTIVA: Inventiva announces a financing of approximately €35 7 million from new and existing investors, consisting of a €30 6 million reserved capital increase and a €5 1 million issuance of royalty certificates

INVENTIVA: Inventiva announces a financing of approximately €35 7 million from new and existing investors, consisting of a €30 6 million reserved capital increase and a €5 1 million issuance of royalty certificates
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesNew yorkFrance generalDavid nikodemPierre broquaPascaline clercAude lepreuxEuropean unionPatricial bankEuropean investment bankFinancial servicesBrunswick groupEuropean parliamentGlobal external affairsCompany board of directors

Castle Biosciences snaps up San Diego s AltheaDx to push precision medicine into mental health

Houston-based company will pay $65 million in cash and stock for AltheaDx, which makes a pharmacogenomics tests to guide clinicians on drug therapies for depression and anxiety.

San diegoUnited statesDerek maetzoldCastle biosciencesDavid nikodemCastle bioscienceWall street

Live Webinar: AltheaDx hosts Dr Kelly Wosnik to share practice patterns of PGx testing

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesAltheadx pgxDavid nikodemKelly wosnikBehnaz sarramiCroom lawrenceBristol healthAltheadx incBristol health oremThurs octoberMedical science liaisonSeasonal affective disorderRandomized controlled trialPr newswireMental health